Literature DB >> 20008147

Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury.

Sean E Gill1, Isham Huizar, Eli M Bench, Samuel W Sussman, Ying Wang, Rama Khokha, William C Parks.   

Abstract

Tissue inhibitor of metalloproteinases 3 (TIMP3) inhibits not only matrix metalloproteinases but also a disintegrin and metalloproteinase domain family members and thus contributes to controlling diverse processes mediated by proteolysis. We used Timp3(-/-) mice to assess the role of this inhibitor in acute lung injury. After bleomycin-induced injury, inflammation, as indicated by the influx of neutrophils in bronchoalveolar lavage (BAL), peaked at 7 days post-injury in the wild-type mice and began to wane thereafter; however, in Timp3(-/-) mice, inflammation persisted up to 28 days. Furthermore, although the level of chemokines in BAL and lung homogenate was similar in both genotypes, BAL from Timp3(-/-) mice 7, 14, and 28 days post-injury had increased neutrophil chemotactic activity compared with wild-type BAL. At day 14, a higher percentage of apoptotic neutrophils were present in wild-type mice compared with Timp3(-/-) mice, further suggesting that TIMP3 constrains continued neutrophil influx. In addition, total matrix metalloproteinase activity was increased in lungs from Timp3(-/-) mice, and treatment of mice with a synthetic inhibitor of metalloproteinases rescued the enhanced neutrophilia phenotype. These data demonstrate that TIMP3 regulates neutrophil influx in the lung following injury through its ability to inhibit metalloproteinase activity and indicates that TIMP3 functions to promote the resolution of inflammation in the lung.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008147      PMCID: PMC2797870          DOI: 10.2353/ajpath.2010.090158

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix.

Authors:  W H Yu; S Yu; Q Meng; K Brew; J F Woessner
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

2.  Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway.

Authors:  Mark Bond; Gillian Murphy; Martin R Bennett; Andrew C Newby; Andrew H Baker
Journal:  J Biol Chem       Date:  2002-02-04       Impact factor: 5.157

3.  Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity.

Authors:  M Bond; G Murphy; M R Bennett; A Amour; V Knauper; A C Newby; A H Baker
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

4.  Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.

Authors:  D K Madtes; A L Elston; L A Kaback; J G Clark
Journal:  Am J Respir Cell Mol Biol       Date:  2001-05       Impact factor: 6.914

5.  Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.

Authors:  M Corbel; S Caulet-Maugendre; N Germain; S Molet; V Lagente; E Boichot
Journal:  J Pathol       Date:  2001-04       Impact factor: 7.996

Review 6.  Tissue inhibitors of metalloproteinases: evolution, structure and function.

Authors:  K Brew; D Dinakarpandian; H Nagase
Journal:  Biochim Biophys Acta       Date:  2000-03-07

Review 7.  Metalloproteinases and their inhibitors: regulators of wound healing.

Authors:  Sean E Gill; William C Parks
Journal:  Int J Biochem Cell Biol       Date:  2007-10-26       Impact factor: 5.085

8.  Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.

Authors:  Fengrong Zuo; Naftali Kaminski; Elsie Eugui; John Allard; Zohar Yakhini; Amir Ben-Dor; Lance Lollini; David Morris; Yong Kim; Barbara DeLustro; Dean Sheppard; Annie Pardo; Moises Selman; Renu A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

9.  Accelerated apoptosis in the Timp-3-deficient mammary gland.

Authors:  J E Fata; K J Leco; E B Voura; H Y Yu; P Waterhouse; G Murphy; R A Moorehead; R Khokha
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

10.  Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3).

Authors:  K J Leco; P Waterhouse; O H Sanchez; K L Gowing; A R Poole; A Wakeham; T W Mak; R Khokha
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

View more
  33 in total

Review 1.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

Review 2.  Matrix metalloproteinases in emphysema.

Authors:  Sina A Gharib; Anne M Manicone; William C Parks
Journal:  Matrix Biol       Date:  2018-03-23       Impact factor: 11.583

Review 3.  Update in acute lung injury and critical care 2010.

Authors:  István Vadász; Jacob I Sznajder
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

Review 4.  Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.

Authors:  Linn Moore; Dong Fan; Ratnadeep Basu; Vijay Kandalam; Zamaneh Kassiri
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

5.  Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction.

Authors:  Vijay Kandalam; Ratnadeep Basu; Thomas Abraham; Xiuhua Wang; Ahmed Awad; Wei Wang; Gary D Lopaschuk; Nobuyo Maeda; Gavin Y Oudit; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

6.  Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury.

Authors:  Claudia Schrimpf; Cuiyan Xin; Gabriella Campanholle; Sean E Gill; William Stallcup; Shuei-Liong Lin; George E Davis; Sina A Gharib; Benjamin D Humphreys; Jeremy S Duffield
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

7.  The myeloid transcription factor KLF2 regulates the host response to polymicrobial infection and endotoxic shock.

Authors:  Ganapati H Mahabeleshwar; Daiji Kawanami; Nikunj Sharma; Yoichi Takami; Guangjin Zhou; Hong Shi; Lalitha Nayak; Darwin Jeyaraj; Robert Grealy; Mary White; Ross McManus; Thomas Ryan; Patrick Leahy; Zhiyong Lin; Saptarsi M Haldar; G Brandon Atkins; Hector R Wong; Jerry B Lingrel; Mukesh K Jain
Journal:  Immunity       Date:  2011-05-12       Impact factor: 31.745

Review 8.  Resolution of organ fibrosis.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

9.  Biphasic response of checkpoint control proteins in hyperoxia: exposure to lower levels of oxygen induces genome maintenance genes in experimental baboon BPD.

Authors:  Kumuda C Das; John D Wasnick
Journal:  Mol Cell Biochem       Date:  2014-06-18       Impact factor: 3.396

10.  TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease.

Authors:  Pavel Zhabyeyev; Subhash K Das; Ratnadeep Basu; Mengcheng Shen; Vaibhav B Patel; Zamaneh Kassiri; Gavin Y Oudit
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-26       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.